Ascendis Pharma EBIT 2015-2024 | ASND
- Ascendis Pharma 2023 EBIT was -0.493B, a 16.71% decline from 2022.
- Ascendis Pharma 2022 EBIT was -0.592B, a 10.74% increase from 2021.
- Ascendis Pharma 2021 EBIT was -0.535B, a 41.53% increase from 2020.
EBIT can be defined as earnings before interest and taxes.